EphrinB2: Expression of a novel potential target in renal cell carcinoma

INTRODUCTION: Renal cell carcinoma (RCC) is primarily managed by surgery with the use of systemic targeted therapy in a metastatic setting. Newer targeted therapeutic options are evolving; Eph-ephrin is a potential new pathway. The therapeutic potential of targeting the EphB4-EphrinB2 pathway has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Chhavi, Sali, Akash Pramod, Jackovich, Alexandra, Ma, Binyun, Sadeghi, Sarmad, Quinn, David, Gill, Parkash, Gill, Inderbir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419785/
https://www.ncbi.nlm.nih.gov/pubmed/37575160
http://dx.doi.org/10.4103/iju.iju_92_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419785/
https://www.ncbi.nlm.nih.gov/pubmed/37575160
http://dx.doi.org/10.4103/iju.iju_92_23

Ejemplares similares